Navigation Links
Neuland Labs Reports Second Quarter Fiscal Year 2013 Financial Results
Date:11/9/2012

HYDERABAD, India, Nov. 9, 2012 /PRNewswire/ -- Neuland Laboratories Ltd., (NSE: NEULANDLAB; BOM: 524558) a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract research and manufacturing services to customers located in 85 countries, today announced financial results for the second quarter of fiscal year (FY) 2013, ended September 30, 2012.

Revenues for the second quarter of FY 2013 were $21.37 million (1.18 billion INR*), compared to revenues in the second quarter of FY 2012 of $22.32 million (1.23 billion INR), a decrease of 4.3%. Neuland reported EBITDA of $2.16 million (119.45 million INR) in the second quarter of FY 2013, compared to EBITDA of $2.02 million (111.84 million INR) in the comparable period in FY 2012, an increase of 6.8%. 

The company reported after-tax profits in the second quarter of FY 2013 of $0.56 million (30.85 million INR), compared to a loss of $0.23 million, (negative12.58 million INR), in the second quarter of FY 2012.  

"In the second quarter of FY 2013 we continued to deliver on our goal of achieving consistently profitable operations," said Dr. D.R. Rao, Chairman and Managing Director of Neuland Labs.  "This is our fourth consecutive quarter of profitability, and the eighth consecutive quarter that we have reported revenues greater than one billion Indian rupees."

"We believe that our investments in marketing and business development are building the foundation for both near and long-term revenue growth," noted Sucheth R. Davuluri, Chief Executive Officer of Neuland Labs.  "Our revenue growth for the first half of fiscal year 2013 is up compared to the first six months of last year, and our enhanced efforts to manage costs resulted in an increase in profits despite the mode
'/>"/>

SOURCE Neuland Laboratories Ltd.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Neuland Labs Reports First Quarter Fiscal Year 2013 Financial Results
2. Neuland Labs Reports Financial Results For Fiscal Year 2012
3. GenVec Reports Third Quarter 2012 Financial Results
4. HeartWare Reports Third Quarter 2012 Results
5. Nephros Reports Third Quarter 2012 Financial Results
6. China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2012
7. CareFusion Reports Preliminary First Quarter Fiscal 2013 Results
8. Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012
9. NxStage Reports Record Revenue for the Third Quarter of Fiscal 2012
10. Discovery Labs Reports Third Quarter 2012 Financial Results
11. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 Kepner-Tregoe ... today announced that 13-year veteran Chris ... Officer. Geraghty,s experience includes more than 20 years ... positions with manufacturing organizations. He succeeds ... serving as Kepner-Tregoe,s Chairman of the Board and ...
(Date:5/21/2013)... May 21, 2013  Zacks.com announces the list of ... Zacks Equity Research analysts discuss the latest news and ... featured in the blog include Actavis, Inc.,s (NYSE: ... SA (NYSE: TOT ), Petrobras (NYSE: PBR ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) ...
(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... Isis Pharmaceuticals,Inc. (Nasdaq: ISIS ) announced ... from a randomized Phase 2 clinical trial of,OGX-011 ... arm"),compared to docetaxel and prednisone alone ("the control ... cancer. The current 10.6,month median overall survival ...
... DIEGO, Dec. 3 Vical Incorporated,(Nasdaq: VICL ... with EIP,Eczacibasi Ilac Pazarlama A.S. (EIP) for sales and ... and the Turkish,Republic of Northern Cyprus. EIP has agreed ... to pay Vical upfront and milestone payments,plus a specified ...
Cached Medicine Technology:Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5
(Date:5/21/2013)... results from SOURCE XT one of the largest, ... reported today at EuroPCR 2013 show good clinical outcomes ... success for all access approaches, valve sizes and delivery ... 2688 consecutively enrolled patients (mean age 81.5 years) undergoing ... centres in 17 countries between July 2010 and October ...
(Date:5/21/2013)... Los Angeles, CA (PRWEB) May 21, 2013 ... titled “Time to Rethink the Use of Botox,” Botox ... the world since their approval in 2002 (Go to goo.gl/8iYbD). ... has become quite popular with men. The injection makes facial ... a single Botox injection last for about three months. This ...
(Date:5/21/2013)... Phoseon Technology will present their advanced ... IMI European Ink Jet Conference (June 5-6, Barcelona, ... to invest in product development to enable breakthrough capability ... curing in printing applications. Phoseon currently has a ... both air cooled and water cooled solutions to match ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 MedMar Healing ... drive to benefit Second Harvest Food Bank. Twenty-eight businesses, including ... participate in the food drive. The goal is to raise ... the economic problems facing their families in recent years. ... community and help those in need,” explains Douglas Chloupek of ...
(Date:5/21/2013)... roles two proteins, thrombospondin-1 and prosaposin, play in ... identified a five-amino acid fragment of prosaposin that ... prostate, breast and lung cancer. The findings suggest ... in a variety of cancers. , The ... Boston Children,s Hospital, Vivek Mittal, PhD, at Weill ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3
... You Are Still Doing Only for OthersSEYMOUR, Tenn., May 1 ... to honor their mothers for all the hard work and ... family first everyday of the year, many times over themselves, ... day designed to celebrate a mother,s love and support can ...
... Boston, MAFollowing the declaration of a public health emergency due ... the Harvard Opinion Research Program at the Harvard School of ... about the outbreak, how they are responding and what they ... about the outbreak , The survey finds that nearly half ...
... Ronald McDonald House Acknowledges Decades of ... more than necessary to keep the non-profit segment ... Ronald McDonald House of Delaware is making sure ... Volunteer Recognition Wall is set to premiere this ...
... 8th Annual National Day to Prevent Teen PregnancyWASHINGTON, May 1 ... rate in the United States increased 5% between 2005 and ... Campaign to Prevent Teen and Unplanned Pregnancy will examine why ... to try to reverse the trend.The forum will take place ...
... National Osteoporosis Foundation calls on Moms to Address Bone Health ... that generations of women have passed on to their loved ... knowledge about health -- especially information about bone health and ... Gift from Mothers to Daughters as the theme for ...
... benefitSAINT PAUL, Minn., May 1 Second Harvest ... honored David Nasby, former vice president of the ... first food bank network, with its inaugural Hunger ... contributions to hunger relief."I am humbled to receive ...
Cached Medicine News:Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 2Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 3Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 2Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 3Health News:Artist Contributes to Volunteer Recognition 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 3Health News:Family History is Key Risk Factor in Developing Osteoporosis 2Health News:Family History is Key Risk Factor in Developing Osteoporosis 3Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 2Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 3
... EBI OsteoGen surgically implanted bone growth stimulator is ... when surgery is already planned or when patient ... is totally surgically implanted, patients are assured of ... hours a day for up to 6 months. ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Interference Screw has unique, double-helix ... while limiting veering and divergence. ... abrasion where it is most ... thread enables screws to be ...
... SmartScrew ACL Interference Screw is indicated ... including ACL and PCL reconstructions with ... and allografts. The SmartScrew ACL provides ... graft retention for any graft type. ...
Medicine Products: